Comparison of 99mTc radiolabeled somatostatin antagonist with [<sup>68</sup> Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.

Authors:
Opalinska M; Lezaic L; Decristoforo C; Kolenc P; Mikolajczak R and 10 more

Journal:
Eur J Nucl Med Mol Imaging

Publication Year: 2023

DOI:
10.1007/s00259-023-06335-9

PMCID:
PMC10611881

PMID:
37452871

View on PubMed View on PMC View Publisher
Journal Information

Full Title: Eur J Nucl Med Mol Imaging

Abbreviation: Eur J Nucl Med Mol Imaging

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Nuclear Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Activated fibroblasts in muscle sarcoidosis revealed by [<sup>18</sup>F]FAPI-74 PET.
Watabe T; Fukusumi T; Inohara H and 7 more (2023) - Transparency Score: 3/6
Adoption of Lutetium-<sup>177</sup> PSMA radioligand therapy for metastatic castration resistant pr…
Flegar L; Thoduka SG; Librizzi D and 9 more (2023) - Transparency Score: 3/6
A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cel…
Rogasch JMM; Michaels L; Baumgärtner GL and 10 more (2023) - Transparency Score: 5/6
Analysis of image data from the EuroNet PHL-C2 trial indicates a potential reduction in injected F-…
Tran-Gia J; Eberlein U; Lassmann M and 10 more (2023) - Transparency Score: 3/6
A phase I/II study of the safety and efficacy of [<sup>177</sup>Lu]Lu-satoreotide tetraxetan in adv…
Wild D; Grønbæk H; Navalkissoor S and 11 more (2023) - Transparency Score: 4/6
View All Papers from This Journal
Transparency Score
2/6
33.3% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
COI Disclosure
Evidence found in paper:

"Funding This research is a part of the project “Novel 99mTc-labelled somatostatin receptor antagonists in the diagnostic algorithm of neuroendocrine neoplasms — a feasibility study” (TECANT), funded by ERA PerMed (ERAPERMED2018-125), including Austrian Science Fund FWF (project no I 4220-B) to Medical University Innsbruck, National Centre for Research and Development (Poland) contracts no ERAPerMed/01/2019 to Jagiellonian University Medical College and no ERA-PerMed/02/2019 to National Centre for Nuclear Research, MIZS (Ministry of Education, Science and Sport) project no C3330- 19–522011 to University Ljubliana and University Medical Centre Ljubljana."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025